Clinical trial
Effect of Hyperglycemia in PAI-1 Activity and the Relationship With Outcome in…
NCT00159952 · Policlinico Hospital, Other · Completed
Key facts
| NCT number | NCT00159952 |
|---|---|
| Title | Effect of Hyperglycemia in PAI-1 Activity and the Relationship With Outcome in Severe Sepsis and Septic Shock |
| Official title | Effect of Hyperglycemia in PAI-1 Activity and the Relationship With Outcome in Severe Sepsis and Septic Shock |
| Lead sponsor | Policlinico Hospital, Other |
| Collaborators | Eli Lilly and Company Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Severe Sepsis, Septic Shock |
| Intervention type | Procedure |
| Interventions | intensive insulin therapy |
| Enrollment | 90 |
| Start date | Nov 1, 2004 |
| Primary completion | Mar 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Sep 12, 2005 |
| Last update posted | Nov 27, 2013 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: